Skip to main content
Premium Trial:

Request an Annual Quote

WuXi PharmaTech Taps NextCode's Software for Sequence Analysis


NEW YORK (GenomeWeb) – WuXi PharmaTech, an R&D capability and technology platform provider, said this week that Chinese researchers who use sequencing services provided by the firm's Genome Center will have access to NextCode Health's sequence analysis solutions.

According to WuXi, NextCode will work with the WuXi Genome Center to process its customers''s sequencing data and to generate reports that will describe the medical implications of the findings.

Financial and other terms of the agreement were not disclosed.

Filed under